CERo Therapeutics Doses 7th Patient in Phase 1 CER-1236 Trial
Seventh patient of the trial at the second cohort
Read the full story on GlobeNewswire → Opens the original article on www.globenewswire.comSummary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.